Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rare bone cancer study seeks DNA clues from patients

NCT ID NCT01200680

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This study aims to collect DNA samples and health information from 188 people in the U.S. and Canada who have sporadic chordoma, a rare bone cancer. Participants will provide saliva samples and fill out a questionnaire at home. The goal is to find genetic changes that may be linked to this disease, which could help researchers understand why it occurs and potentially lead to better ways to detect or treat it in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Westat, Inc.

    Rockville, Maryland, 20850, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal genetic factors behind sporadic chordoma, pointing toward future risk assessment or targeted therapies.

What could go wrong

This is an observational study, not a treatment trial. It may not identify clear genetic links, and results may take years to impact patient care.

Conditions

The condition(s) this trial relates to.

chordoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.